| 1 | 0 mg Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 44 44 💬
|
| 2 | 5 mg Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 44 44 💬
|
| 3 | [Glucocorticoids (GC)] | - | - | - | - | 2件: 43 43, 44 💬
|
| 4 | [GSK3511294] | - | - | - | - | 2件: 44 44, 45 💬
|
| 5 | [IFX-1] | - | - | - | - | 2件: 43 43, 44 💬
|
| 6 | [L04AC06] | - | - | - | - | 2件: 44 44, 45 💬
|
| 7 | [MEDI-563] | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 💬
|
| 8 | [Mepolizumab] | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 9 | AB-101 | - | - | - | - | 4件: 35 35, 44, 46, 49 💬
|
| 10 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 14件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 28件: 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 11 | Abatacept (CTLA4-Ig) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 14件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 44 44 💬
|
| 12 | ALEMTUZUMAB | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 21件: 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 13 | Anti-interleukin 5 (IL-5) humanized monoclonal | - | - | - | - | 2件: 44 44, 45 💬
|
| 14 | Avacopan | 1件: Avacopan Avacopan | 1件: Avacopan
Avacopan
💬
| 1件: C5AR1 C5AR1 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | 4件: 43 43, 44, 66, 223 💬
|
| 15 | Azathioprin-ratiopharm® 25 mg Filmtabletten | - | - | - | - | 1件: 44 44 💬
|
| 16 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 26件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 17 | Azathioprine 25 mg | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 44 44 💬
|
| 18 | AZD7986 | - | - | - | - | 2件: 44 44, 299 💬
|
| 19 | BELIMUMAB | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 17件: 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 20 | Benralizumab | 1件: Benralizumab Benralizumab | 1件: Benralizumab
Benralizumab
💬
| 1件: IL5RA IL5RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 💬
|
| 21 | Blisibimod | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬
| - | - | 5件: 43 43, 44, 49, 63, 66 💬
|
| 22 | CCX168 | - | - | - | - | 6件: 43 43, 44, 49, 66, 109, 223 💬
|
| 23 | Chimeric monoclonal antibody, IgG4 subtype | - | - | - | - | 2件: 43 43, 44 💬
|
| 24 | Corticosteroid | - | - | - | - | 12件: 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
|
| 25 | Corticosteroid and azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 4件: 42 42, 43, 44, 45 💬
|
| 26 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 50件: 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 27 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | 3件: Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | 6件: Methotrexate
Methotrexate
,
Azathioprine
,
Cyclophosphamide
,
Methotrexate sodium
,
Azathioprine sodium
,
Cyclophosphamide
💬
| 2件: DHFR DHFR, DHFR2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 28 | Cyclophosphamide/azathioprine | 2件: Azathioprine Azathioprine, Cyclophosphamide | 4件: Azathioprine
Azathioprine
,
Cyclophosphamide
,
Azathioprine sodium
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
| 29 | Cyclophosphamidum 500 mg | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
| 30 | Dengue 1,2,3,4 (attenuated) vaccine | - | - | - | - | 8件: 40 40, 43, 44, 46, 48, 49, 51, 107 💬
|
| 31 | Depemokimab | 1件: Depemokimab Depemokimab | 1件: Depemokimab
Depemokimab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 32 | Diagnostic Test: laboratory experiments before and after mepolizumab treatment | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 33 | Diagnostic Test: Procalcitonin-variants ELISA-Assay | 1件: Procalcitonin Procalcitonin | - | - | - | 2件: 43 43, 44 💬
|
| 34 | Endoxan® 500 mg | - | - | - | - | 1件: 44 44 💬
|
| 35 | Fasenra | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 💬
|
| 36 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 30件: 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 37 | GALEN® tablet | - | - | - | - | 2件: 43 43, 44 💬
|
| 38 | Glucocorticoid (GC) | - | - | - | - | 3件: 43 43, 44, 46 💬
|
| 39 | Glucocorticoids | - | - | - | - | 13件: 35 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
|
| 40 | Glucocorticoids (GC) | - | - | - | - | 2件: 43 43, 44 💬
|
| 41 | Glucocorticoids - Reduced Dose | - | - | - | - | 2件: 43 43, 44 💬
|
| 42 | Glucocorticoids - Standard Dose | - | - | - | - | 2件: 43 43, 44 💬
|
| 43 | Glucocorticoids [Reduced Dose] | - | - | - | - | 2件: 43 43, 44 💬
|
| 44 | Glucocorticoids [Standard Dose] | - | - | - | - | 2件: 43 43, 44 💬
|
| 45 | GSK3511294 | - | - | - | - | 2件: 44 44, 45 💬
|
| 46 | Gusperimus | 1件: Gusperimus Gusperimus | 2件: Gusperimus trihydrochloride
Gusperimus trihydrochloride
,
Gusperimus
💬
| - | - | 1件: 44 44 💬
|
| 47 | Gusperimus + glucocorticoids | 1件: Gusperimus Gusperimus | 2件: Gusperimus trihydrochloride
Gusperimus trihydrochloride
,
Gusperimus
💬
| - | - | 1件: 44 44 💬
|
| 48 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 29件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
|
| 49 | Idefirix | - | - | - | - | 3件: 43 43, 44, 113 💬
|
| 50 | IFX-1 | 1件: Vilobelimab Vilobelimab | 1件: Vilobelimab
Vilobelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 43 43, 44, 269 💬
|
| 51 | Imlifidase | 1件: Imlifidase Imlifidase | 1件: Imlifidase
Imlifidase
💬
| - | - | 4件: 43 43, 44, 113, 221 💬
|
| 52 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | 2件: 43 43, 44 💬
|
| 53 | IMUREL | - | - | - | - | 7件: 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 54 | IMUREL 25 mg | - | - | - | - | 3件: 44 44, 45, 96 💬
|
| 55 | INS1007 | - | - | - | - | 2件: 44 44, 299 💬
|
| 56 | L04AC06 | - | - | - | - | 2件: 44 44, 45 💬
|
| 57 | Mabthera | - | - | - | - | 20件: 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 58 | Mabthera® | - | - | - | - | 7件: 13 13, 35, 43, 44, 46, 63, 93 💬
|
| 59 | MEDI-563 | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 💬
|
| 60 | Meperizumab injection | - | - | - | - | 1件: 44 44 💬
|
| 61 | MEPOLIZUMAB | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 4件: 44 44, 45, 98, 162 💬
|
| 62 | Mepolizumab 100 MG Injection [Nucala] | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 63 | Mepolizumab 300 mg | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 3件: 44 44, 45, 98 💬
|
| 64 | Mepolizumab Injection | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 44 44 💬
|
| 65 | Mesna | 1件: Coenzyme M Coenzyme M | 1件: Mesna
Mesna
💬
| - | - | 12件: 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 66 | Metex 2,5 mg Tabletten | - | - | - | - | 1件: 44 44 💬
|
| 67 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 41件: 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 68 | Methotrexate 2.5 mg | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 69 | Methotrexate 25 mg | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 70 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 51件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 71 | METOJECT 10 mg/ml, solution injectable en seringue pré-remplie | - | - | - | - | 1件: 44 44 💬
|
| 72 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH1 IMPDH1, IMPDH2 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 38件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 73 | Mycophénolate mofétil | - | - | - | - | 1件: 44 44 💬
|
| 74 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 14件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
|
| 75 | NALTREXONE HYDROCHLORIDE | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 76 | NS-229 | - | - | - | - | 2件: 44 44, 45 💬
|
| 77 | NUCALA | - | - | - | - | 2件: 44 44, 45 💬
|
| 78 | Nucala 100 mg powder for solution for injection | - | - | - | - | 2件: 44 44, 45 💬
|
| 79 | NUCALA® | - | - | - | - | 1件: 44 44 💬
|
| 80 | Obinutuzumab | 1件: Obinutuzumab Obinutuzumab | 1件: Obinutuzumab
Obinutuzumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 6件: 43 43, 44, 49, 63, 222, 223 💬
|
| 81 | ORENCIA | - | - | - | - | 16件: 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 82 | Other: Active Comparator | - | - | - | - | 2件: 43 43, 44 💬
|
| 83 | Other: Blood sample | - | - | - | - | 37件: 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 84 | Other: Blood samples and clinical data | - | - | - | - | 1件: 44 44 💬
|
| 85 | Other: No Plasma Exchange | - | - | - | - | 2件: 43 43, 44 💬
|
| 86 | Pednisone | - | - | - | - | 2件: 43 43, 44 💬
|
| 87 | Plaquenil - Hydroxychloroquine 200mg Film coated tablets | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 3件: 43 43, 44, 45 💬
|
| 88 | Plasma exchange | - | - | - | - | 7件: 13 13, 43, 44, 64, 95, 171, 222 💬
|
| 89 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 90 | Prednison acis® 20 mg | - | - | - | - | 2件: 43 43, 44 💬
|
| 91 | Prednison acis® 5 mg | - | - | - | - | 2件: 43 43, 44 💬
|
| 92 | Prednison acis¿ 20 mg | - | - | - | - | 2件: 43 43, 44 💬
|
| 93 | Prednison acis¿ 5 mg | - | - | - | - | 2件: 43 43, 44 💬
|
| 94 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 58件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 95 | PredniSONE Tablets, USP | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 41 41, 43, 44 💬
|
| 96 | Procalcitonin | 1件: Procalcitonin Procalcitonin | - | - | - | 3件: 43 43, 44, 299 💬
|
| 97 | Rapcabtagene autoleucel | - | - | - | - | 5件: 43 43, 44, 46, 49, 51 💬
|
| 98 | Recombinant humanized monoclonal antibody specific for human IL-5 | - | - | - | - | 1件: 44 44 💬
|
| 99 | Reslizumab | 1件: Reslizumab Reslizumab | 1件: Reslizumab
Reslizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 98 💬
|
| 100 | RITUXIMAB | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 54件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 101 | Rituximab (Arm A) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 💬
|
| 102 | Rituximab (Arm B) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 43 43, 44, 63 💬
|
| 103 | Rituximab (R) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 43, 44 💬
|
| 104 | RO0452294/V01 | - | - | - | - | 2件: 43 43, 44 💬
|
| 105 | RO0452294/V02 | - | - | - | - | 3件: 35 35, 43, 44 💬
|
| 106 | RoActemra | - | - | - | - | 7件: 41 41, 44, 46, 51, 86, 107, 271 💬
|
| 107 | SB-240563 | - | - | - | - | 3件: 44 44, 45, 98 💬
|
| 108 | SB-240563 (mepolizumab) | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 109 | SHR-1703 | - | - | - | - | 1件: 44 44 💬
|
| 110 | Standard of Care (SOC) | - | - | - | - | 5件: 43 43, 44, 49, 85, 171 💬
|
| 111 | Sulfamethoxazole | 1件: Sulfamethoxazole Sulfamethoxazole | 1件: Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | 8件: 35 35, 44, 49, 61, 85, 223, 296, 299 💬
|
| 112 | Tezepelumab | 1件: Tezepelumab Tezepelumab | 1件: Tezepelumab
Tezepelumab
💬
| 1件: TSLP TSLP 💬
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 3件: 44 44, 45, 98 💬
|
| 113 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 26件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 114 | Tofacitinib | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 23件: 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 115 | Trimethoprim | 1件: Trimethoprim Trimethoprim | 3件: Trimethoprim
Trimethoprim
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | 7件: 36 36, 44, 49, 60, 61, 85, 299 💬
|
| 116 | Trimethoprim Sulfamethoxazole | 2件: Sulfamethoxazole Sulfamethoxazole, Trimethoprim | 4件: Trimethoprim
Trimethoprim
,
Sulfamethoxazole
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | 1件: 44 44 💬
|
| 117 | Vilobelimab | 1件: Vilobelimab Vilobelimab | 1件: Vilobelimab
Vilobelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 43 43, 44, 269 💬
|
| 118 | Vitamin D | 1件: Vitamin D Vitamin D | - | - | - | 26件: 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 119 | Whole Blood | 1件: Whole Blood Whole Blood | 1件: Blood, whole
Blood, whole
💬
| - | - | 9件: 44 44, 45, 50, 65, 86, 177, 226, 283, 299 💬
|
| 120 | Yellow fever vaccine | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: Yellow fever vaccine
Yellow fever vaccine
💬
| - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 💬
|
| 121 | Yellow Fever vaccine (17D) | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: Yellow fever vaccine
Yellow fever vaccine
💬
| - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 💬
|